WO2018069756A1

WO2018069756A1 - Devices and methods for warming of a cryopreserved biological sample

Info

Publication number: WO2018069756A1
Application number: PCT/IB2017/000465
Authority: WO
Inventors: Amir Arav; Yehudit Natan; Pasquale Patrizio
Original assignee: Fertilesafe Ltd.
Priority date: 2016-10-13
Filing date: 2017-04-04
Publication date: 2018-04-19

Abstract

A system (1000) for use in warming, thawing, cooling, and reconstituting a cryopreserved biological sample (102) is disclosed, which includes a heating system (1100) including a container with an insulating wall defining a chamber to retain a cryogenic fluid (1104), and a receiving space to removably receive a receptacle configured and dimensioned to retain a warming solution (1106). The sample is movable from the cryogenic fluid into the warming solution in an interval of time that results in reduced air exposure and an increased warming rate. A cooling system (1200) is also disclosed for cooling the warmed sample to e.g. room temperature, which includes a repository (1202) that accommodates a series of containers (1204A-1204D) including respective solutions, which achieves simultaneous purging of cryoprotectant from the biological sample, and cooling of the biological sample. A retaining device comprising a tubular member (straw) and a perforated member is also disclosed.

Description

DEVICES AND METHODS FOR WARMING OF A CRYOPRESERVED

BIOLOGICAL SAMPLE

TECHNICAL FIELD

This application generally relates to devices for micromanipulation of biological samples, and more specifically, for vitrification, cuituring, cryopreservation, thawing and/or warming of biological samples and methods for using the devices.

BACKGROUND OF THE INVENTION

Preservation of biological samples, for example oocytes and embryos at very low temperature, is known as cryopreservation. One of the major challenges of cryopreservation is to prevent the intracellular liquid within the sample from turning into ice crystals. Two common techniques of cryopreservation are slow freezing and vitrification.

During the slow freezing process ice crystals are formed intercellularly, and as a result the remaining liquid becomes hypertonic thus allowing intracellular water to leave the cells and to pass towards an outside of the cells by exosmosis, thus preventing intracellular crystallization.

In vitrification, intercellular and intracellular water crystallization is avoided by means of a very high cooling rate. According to some vitrification protocols, the sample is plunged into a very cold cryogenic medium, e.g. , liquid nitrogen (LN) or LN slush, thus resulting in very high cooling rates, which enables vitrification rather than crystallization of the intracellular and intercellular liquids.

In some protocols, vitrification may be further enabled by increasing the viscosity of the sample, for example by applying various cryoprotectants and/or other applicable additives, by reducing the volume of the sample, or by a combination thereof. For example, the publication "Vitrification of oocytes and embryos" (Amir Arav, "Embryonic development and manipulation in animal development", edited by A. Lauria and F. Gandolfi, Portland Press, London, U.K., 1992) discloses a method of vitrifying cells enclosed in small drops sufficient to keep them in physiological conditions. In this publication, Arav reports that with volume of 70 nanoliter drops, good survival rates can be achieved even with low concentration of cryoprotectant.

Vitrification is further described in the following publications:

"Titration of Vitrification Solution in Mouse Embryo Cryopreservation" (A. ARAV, L. GlANAROLl, AND P. SURIANO, Cryobiology 25(6), 1988) discloses reducing the toxicity of the vitrification solution by decreasing the time and temperature of embryo exposure to cryoprotectant solution.

"Osmotic and cytotoxic study of vitrification of immature bovine oocytes" (A. Arav, D. Shehu, and M. Mattioli, Journal of Reproduction and Fertility, 99: 353-358, 1993) discloses experiments conducted in order to determine the composition of a solution suitable for vitrification of immature bovine oocytes.

"New trends in gamete's cryopreservation" (Amir Arav, Saar Yavin, Yoel Zeron, Dity Natan, Izik Dekel, and Haim Gacitua. Molecular and Cellular Endocrinology, 187: 77-81 , 2002) discloses techniques to improve freezing and vitrification of sperm, oocytes and embryos, based on 'Multi-Thermal-Gradient' (MTG) freezing.

"Measurement of essential physical properties of vitrification solutions" (S. Yavin and A. Arav. Theriogenology, 67(1): 81-9, 2007) examines the principal parameters associated with successful vitrification, and composes guidelines to aspects of the vitrification process.

"Embryo cryopreservation in the presence of low concentration of vitrification solution with sealed pulled straws in liquid nitrogen slush" (Saar Yavin, Adaya Aroyo, Zvi Roth, and Amir Arav. Human Reproduction, 24(4): 797-804, 2009) presents a vitrification method that combines LN slush and sealed pulled straws (SPS).

U.S. Patent Publication 201 1/02071 12 (Burbank and Jones, published in 201 1) discloses an automated system and method of cryopreservation and reanimation of oocytes, embryos, or blastocysts. One or more oocytes or embryos are positioned in a processing container, the processing container being configured to allow fluid to flow into and out of the processing container, where two or more fluids flow into and out of the processing container with oocytes or embryos therein.

PCT publication WO/2014/088514 (NG and Vajta, published in 2014) relates to a method of producing at least one vitrified cell comprising loading a cell into a holding space in at least one conduit; providing at least one cryoprotectant to the holding space of the conduit in increasing concentrations, wherein the cryoprotectant is capable of equilibrating the cell; cooling the cell in the holding space of the conduit to produce a vitrified cell; and storing and maintaining the vitrified cell in the holding space of the conduit.

Moreover, it is well known that the rate at which biological samples are warmed and reconstituted following vitrification plays an important role in determining the success of the cryopreservation procedure. Typically, increased warming rates yield more successful results.

Known cryopreservation procedures and methods are time consuming. Requirements of additional time add to the cost of preservation and the procedure. Gradual and accurate exposure to cryoprotectants, e.g., via robotic automation, also reduces the risk of osmotic shock. Additionally, current cryopreservation procedures and methods have limited volumes/sample capabilities. For example, in current systems the sample, e.g. eggs, is moved one by one into various solutions for cryopreservation. This limits the number of samples and can add to the complexity of the procedure. It would be advantageous to provide a system which not only simplifies the procedure, but speeds the process of cryopreservation and enables a greater number of samples to be preserved in a shorter period of time. It would be further advantageous to include automation during cryopreservation to standardize the procedure and thereby increase consistency of the clinical results.

Additionally, known protocols for warming and reconstituting cryopreserved biological samples often involve moving a cryopreserved biological sample between locations and/or devices, which is inefficient and requires more time than may otherwise be necessary to reconstitute biological samples, thus potentially compromising the results of the procedure. Additionally, know protocols for warming cryopreserved samples often expose the sample to room temperature before warming which also can adversely affect the sample. It would be advantageous to provide a system that reduces the overall time required for warming and thawing of a cryopreserved biological sample, thus increasing the overall likelihood of success and efficacy of the procedure, reducing the potential for damage of the sample. It would be further advantageous to provide a system that automates the transfer of a cryopreserved biological sample during warming and thawing to provide standardization, and thus increase consistency of the clinical results, and the standard of patient care.

SUMMARY OF THE INVENTION

The present invention provides a system and method for cryopreservation of biological samples in a quick and efficient way enabling preservation of a relatively large number of samples. The present invention also provides a system and method of warming, reconstituting and/or rehydrating a biological sample that underwent vitrification. These systems of cryopreservation and warming/thawing can be used independent of one another. However, the present invention also provides a complete system and method that provides for both cryopreservation of a biological sample and subsequent warming and treatment of the cryopreserved sample.

In accordance with one aspect of the present invention relating to cryopreservation, a device for retaining a biological sample for performing a cryoprocedure on the biological sample is provided, the device comprising a tubular member having a lumen extending therein configured to receive the biological sample and a retainer couplable to a distal end of the tubular member, the retainer having a perforated member having at least one orifice. The at least one orifice has a dimension smaller than a dimension of the at least one biological sample to prevent exit of the biological sample from the tubular member, wherein the perforated member is configured to allow inflow of liquids to communicate with the lumen containing the biological sample.

In some embodiments, the tubular member forms a capillary duct to draw the biological sample into the tubular member. In some embodiments, a separate component is couplable to the tubular member after the biological sample is within the tubular member. In some embodiments, the retainer and tubular member are couplable by a frictional fit. In some embodiments, the retainer has a first shrinking coefficient and the tubular member has a second shrinking coefficient to provide a pressure fit upon a change in temperature. In some embodiments, the tubular member includes a pump disposed at a proximal end.

In some embodiments, the retainer has a circumferential wall inserted into the distal end of the tubular member; in other embodiments the distal end of the tubular member is inserted into a space within the circumferential wall.

In some embodiments, the perforated member comprises a mesh.

In accordance with another aspect of the present invention, a device for retaining multiple biological samples for a cryoprocedure is provided, the device including a tubular member having a lumen configured to receive a plurality of biological samples and a restrictor at a distal end configured to prevent exiting of the biological samples from the tubular member while enabling inflow of fluid to contact biological samples.

In some embodiments, the restrictor comprises a member having a plurality of orifices, the orifice having a dimension smaller than a dimension of the biological samples. In some embodiments, the tubular member forms a capillary duct to draw the biological samples in a proximal direction. In some embodiments, the restrictor is positioned within a second member couplable to the tubular member after the biological samples are positioned in the lumen of the tubular member.

In accordance with another aspect of the present invention, a method for performing a cryoprocedure on a biological sample is provided comprising: a) loading the biological sample into a tubular member; b) positioning the tubular member in a first solution with the biological sample retained therein; c) removing the tubular member from the first solution with the biological sample retained therein; and d) positioning the tubular member in a second solution with the biological sample retained therein.

In some embodiments, the step of loading the biological sample is performed by capillar)' action. In some embodiments, the step of loading the biological sample is performed by pumping-in the biological sample.

The first and second solutions in some embodiments can have different densities.

In some embodiments, a plurality of biological samples are loaded into the tubular member and the plurality of biological samples are together positioned in the solutions.

In some embodiments, the sample is retained by a perforated member, the perforated member having at least one orifice having a dimension smaller than a dimension of the biological sample to prevent exit of the biological sample from the tubular member, wherein the perforated member is configured to allow inflow of liquids to communicate with the lumen containing the biological sample. In some embodiments, the perforated member is positioned in a holding member, and the holding member is couplable to the tubular member.

The present invention also provides in another aspect a device configured to perform a cryoprocedure on at least one biological sample comprising a straw comprising a straw space, configured to draw liquid from a distal end of the straw space towards a proximal end of the straw space and a pod coupled to a distal end of the straw. The pod includes a holding space and a perforated member comprising at least one orifice whose diameter is smaller than the diameter of the at least one biological sample, wherein the perforated member is configured to allow inflow of liquids into the preparation space and outflow of liquids from the preparation space. The holding space is configured to form, together with the straw space, a preparation space wherein the at least one biological sample can undergo the cryoprocedure.

The at least one orifice can have a circular cross section, a square cross-section or other shapes. In some embodiments, a pump can be coupled to a proximal end of the straw. In some embodiments, the straw is a capillary duct and the straw space is a capillary space. In accordance with another aspect of the present invention, a pod is provided couplable to a straw that is configured for performing a cryoprocedure on at least one biological sample, the pod comprising a holding space configured to form, upon coupling with the straw, a preparation space together with a straw space and a perforated member comprising at least one orifice whose diameter is smaller than the diameter of the at least one biological sample, wherein the perforated member is configured to allow inflow of liquids used for the cryoprocedure into the holding space and outflow of liquids from the holding space.

In accordance with another aspect of the present invention there are provided methods for performing a cryoprocedure on at least one biological sample in a straw, comprising: loading the at least one biological sample into a straw; exposing the at least one sample in the straw to solutions with gradually changing densities, while preventing the at least one sample from flowing out of the straw.

In some embodiments, the loading the at least one biological sample is performed by capillary action. In other embodiments, the loading the at least one biological sample is performed by pumping-in the at least one sample. In other embodiments, the loading of the at least one biological sample is performed by utilizing the communicating vessels concept.

In some embodiments, the step of exposing is performed by replacing solutions in the straw, in other embodiments by capillary action and in other embodiments by loading layers of gradually changing solutions into the straw.

In accordance with another aspect of the present invention, a system is provided for use in warming and thawing a cryopreserved biological sample including a heating subsystem that is configured and dimensioned to heat the biological sample to a first temperature. The heating subsystem includes a container with an insulating wall defining a chamber that is configured and dimensioned to retain a cryogenic fluid that maintains cryopreservation of the biological sample, and a receiving space that is configured and dimensioned to removably receive a receptacle, e.g., a tube. The receptacle is configured and dimensioned to retain a warming solution such that the cryogenic fluid and the warming solution are positioned in close proximity, whereby the biological sample is movable from the cryogenic fluid into the warming solution in an interval of time that results in reduced air exposure and an increased warming rate to reduce any potential for cellular damage during warming and thawing of the biological sample following cryopreservation. In some embodiments, the interval can be between about 0.1 and about 5 seconds by way of example. Other time intervals are also contemplated.

In another aspect of the present invention, a system is provided for use in warming and thawing a cryopreserved biological sample. The system includes a heating subsystem that is configured and dimensioned to raise the temperature of the biological sample. The heating subsystem includes a container that retains both a cryogenic fluid for maintaining cryopreservation of the biological sample, and a warming solution in close proximity such that the biological sample is movable from the cryogenic fluid into the warming solution in an interval of time resulting in reduced air exposure and an increased warming rate to reduce cellular damage during warming and thawing of the biological sample following cryopreservation.

In another aspect of the present invention, a system is provided for use in warming and thawing a cryopreserved biological sample. The system includes a heating system configured and dimensioned to raise a temperature of the biological sample. The heating system includes a container retaining a cryogenic fluid, which maintains cryopreservation of the biological sample, and a warming solution in close proximity such that the biological sample is movable from the cryogenic fluid into the warming solution in an interval of time resulting in reduced air exposure and an increased warming rate to reduce cellular damage during warming and thawing of the biological sample following cryopreservation.

In some embodiments, the container may include an insulating wall that separates the cryogenic fluid and the warming solution. In some embodiments, the insulating wall may define a chamber configured and dimensioned to retain the cryogenic fluid, and a receiving space configured and dimensioned to receive a receptacle configured and dimensioned to retain the warming solution. In some embodiments, the insulating wall may separate the receptacle from the cryogenic fluid such that the biological sample is movable from the cryogenic fluid into the warming solution in an interval of time within the range of about .1 seconds to about 5 seconds. In some embodiments, the insulating wall may define an inwardly extending shoulder configured and dimensioned to provide a seat for the holder.

In some embodiments, the system may further include a holder positioned within the receiving space that is configured and dimensioned to receive the receptacle.

In some embodiments, the insulating wall may define a thickness within the range of about 0.5 cm to about 10 cm such that the biological sample is movable from the cryogenic fluid into the warming solution in an interval of time within the range of about 0.1 seconds to about 5 seconds.

In some embodiments, the container may further include a temperature control unit to heat the warming solution to a desired temperature. The temperature control unit may include a programmable controller to facilitate regulation of the temperature of the warming solution.

In some embodiments, the system may further include a cooling system to cool the biological sample from the first temperature to a second temperature. The cooling system may include a repository accommodating a plurality of containers retaining solutions, e.g., a first container retaining a first solution in a first volume, and a second container retaining a second solution in a second volume greater than the first volume.

In some embodiments, the first solution and the second solution may be the same, e.g., may include the same components/ingredients, except that the first solution may be more dense than the second solution, i.e., the components/ingredients in the first solution may be present in different concentrations than in the second solution. In some embodiments, the first solution may include about 2 ml of 1 sucrose solution in holding medium, and the second solution may include about 3 ml of .5M sucrose solution in holding medium. In some embodiments, the first and second solutions may each be held at temperatures within the range of about 22°C to about 24°C.

In some embodiments, the repository may include a temperature control unit to regulate temperature of the first solution and the second solution. In another aspect of the present invention, a system is provided for warming a cryopreserved biological sample. The system includes a container having an insulating wall defining first and second areas, wherein the first area is configured and dimensioned to receive a cryogenic fluid to maintain cryopreservation of the sample, and the second area is configured and dimensioned to receive a warming solution to warm the biological sample.

In some embodiments, the system may further include a cooling system having a plurality of containers configured and dimensioned to receive solutions to progressively remove cryoprotectant from the biological sample.

In accordance with another aspect of the present invention, a system is provided for treating a biological sample after being cryopreserved and warmed. The system includes a cooling system to cool the biological sample from a first temperature to a second cooler temperature. The cooling system includes a repository retaining a plurality of containers, e.g., a first container retaining a first solution, and a second container retaining a second solution. The biological sample is movable from the first solution to the second solution to remove cryoprotectant.

In some embodiments, the biological sample may be contained in a tube having a perforated member at a distal end, wherein the tube is insertable into the first container and then into the second container.

In some embodiments, the second temperature may be about room temperature. In some embodiments, the system may further include a temperature control unit having a programmable controller to facilitate regulation of the temperature of the first and second solutions.

In another aspect of the present invention, a method of warming and thawing a cryopreserved biological sample is provided that includes removing the biological sample from a cryogenic fluid retained within a chamber defined by an insulating wall of a container, and inserting the biological sample into a warming solution retained within a receiving space defined by the insulating wall of the container. In some embodiments, inserting the biological sample into the warming solution may include passing the biological sample through vapor formed by the cryogenic fluid. In some embodiments, removing the biological sample from the cryogenic fluid and inserting the biological sample into the warming solution may be completed in an interval of time within the range of about .0.1 seconds to about 5 seconds.

In some embodiments, the method may further include removing the biological sample from the warming solution, and inserting the biological sample into a first solution. In some embodiments, the method may further include removing the biological sample from the first solution and inserting the biological sample into a second solution, wherein the first solution is more dense than the second solution. In some embodiments, inserting the biological sample into the first solution may include inserting the biological sample into 2 ml of 1 M sucrose solution in holding medium at 37°C, and inserting the biological sample into the second solution may include inserting the biological sample into 3 ml of .5M sucrose solution in holding medium at 22°C.

In accordance with another aspect of the present invention, a cryopreservation and warming/thawing system is disclosed for use in preserving a biological sample that includes a device for retaining a biological sample for performing a cryoprocedure on the biological sample, and a heating system configured and dimensioned to receive the device and heat the biological sample to a first temperature following the cryoprocedure. The device can include a tubular member having a lumen extending therein and a perforated member.

In some embodiments, the system may further include a cooling system configured and dimensioned to cool the biological sample from the first temperature to a second temperature following removal from the heating system. In some embodiments, the cooling system may include a repository accommodating a plurality of containers retaining solution to remove cryoprotectant step by step from the biological sample.

In some embodiments, the device may further include a retainer couplable to a distal end of the tubular member, wherein the retainer includes the perforated member, which may have at least one orifice defining a dimension smaller than a dimension of the at least one biological sample to prevent exit of the biological sample from the tubular member.

In some embodiments, the perforated member may be configured to allow inflow of liquids to communicate with the lumen containing the biological sample. In some embodiments, the perforated member may include a mesh.

In some embodiments, the heating system may include a container with an insulating wall defining a chamber configured and dimensioned to retain a cryogenic fluid.

In some embodiments, the insulating wall may further define a receiving space configured and dimensioned to removably receive a receptacle configured and dimensioned to retain a warming solution such that the cryogenic fluid and the warming solution are positioned in close proximity, whereby the biological sample is movable from the cryogenic fluid into the warming solution in an interval of time that results in reduced air exposure and an increased warming rate to reduce cellular damage. In some embodiments, the insulating wall may separate the receptacle from the liquid nitrogen and defines a thickness within the range of about 0.5 cm to about 10 cm, whereby the interval of time is within the range of about 0.1 seconds to 5 seconds.

In some embodiments, the container may further include a temperature control unit to heat the warming solution to a desired temperature.

In some embodiments, the system may further include a plurality of containers containing solutions of different densities. In some embodiments, the containers may contain solutions of different densities which receive the biological sample step by step to add cryoprotectant to the biological sample. In some embodiments, the containers may contain solutions of different densities which receive the biological sample step by step to remove cryoprotectant from the biological sample.

In some embodiments, the cooling system may include a temperature control unit. In another aspect of the present invention, a method is disclosed for a cryopreservation, and subsequent warming and thawing, of a biological sample. The method includes loading the biological sample into a tubular member, positioning the tubular member and the biological sample in a cryogenic fluid, removing the tubular member and the biological sample from the cryogenic fluid, and positioning the tubular member and the biological sample in a warming solution held within the container.

In some embodiments, positioning the tubular member and the biological sample may include retaining the biological sample within the tubular member with a perforated member having at least one orifice defining a dimension smaller than a dimension of the biological sample to prevent exit of the biological sample from the tubular member.

In some embodiments, removing the tubular member and the biological sample from the cryogenic fluid may include removing the tubular member and the biological sample from a chamber defined by an insulating wall of the container.

In some embodiments, positioning the tubular member and the biological sample in the warming solution may include inserting the biological sample into a receiving space defined by the insulating wall of the container. In some embodiments, positioning the tubular member and the biological sample in the warming solution may include passing the biological sample through vapor formed by the cryogenic fluid. In some embodiments, removing the tubular member and the biological sample from the cryogenic fluid and positioning the biological sample in the warming solution may be completed in an interval of time within the range of about 0.1 seconds to about 5 second.

In some embodiments, the method may further include removing the tubular member and the biological sample from the warming solution, and inserting the tubular member and the biological sample into a first cooling solution. In some embodiments, the method may further include removing the tubular member and the biological sample from the first cooling solution and inserting the tubular member and the biological sample into a second cooling solution. In some embodiments, the first cooling solution and the second cooling solution may include the same components. In some embodiments, the first solution may be more dense than the second solution.

BRIEF DESCRIPTION OF THE DRAWINGS

In order to understand the invention and to see how it may be carried out in practice, embodiments will now be described, by way of non-limiting example only, with reference to the accompanying drawings, in which:

Fig. 1 is a perspective view of one embodiment of a capillary device of the present invention configured to apply cryoprocedures to a biological sample and further having a pod fully inserted into the capillary device;

Fig. 2a is a perspective view of one embodiment of a pod of the present invention, shown prior to attachment to a capillary device;

Fig. 2b is a cutaway view of the pod of Fig. 2a;

Fig. 2c is a perspective view of another alternate embodiment of a pod of the present invention having a circumferential wall with a polygonal cross section,

Fig. 2d is a cutaway view of the pod of Figure 2a illustrating a biological sample in a longitudinal cut of an orifice formed in the pod;

Figs. 2e and 2f are perspective views of another alternate embodiment of a pod of the present invention with Fig. 2e showing a cutaway view and Fig. 2f showing the entire pod;

Figs. 2g, 2h, 2i, 2j and 2k schematically illustrate two-dimensional representations of alternate embodiments of pods of the present invention;

Figs. 3a, 3b and 3c are perspective views illustrating the coupling of the pod of Fig. 2a with the capillary device of Fig. 1 , both shown in a cutaway view; Fig. 4 is a flowchart illustrating the procedures taken to prepare a sample for vitrification in accordance with one embodiment of the present invention;

Fig. 5 is a side view of a tube, e.g., straw, of the present invention having four different layers of liquid therein in accordance with the present invention;

Fig. 6 is a flowchart illustrating procedures taken in order to prepare a sample for vitrification in accordance with an alternate embodiment of the present invention;

Figs. 7a, 7b and 7c illustrate stages of loading the tube of Fig. 5 in accordance with the method of Fig. 6;

Figs. 8a, 8b, 8c and 8d illustrate loading four solutions into a tube in accordance with an embodiment of the present invention;

Fig. 9 illustrates one embodiment of a warming and thawing system of the present invention including a heating subsystem and a cooling subsystem;

Fig. 10 is a cross-sectional view of the heating subsystem of Fig. 9;

Fig. 1 1 is an enlargement of the area of detail indicated in Fig. 10;

Fig. 12 is a partial, cross-sectional view of the heating subsystem of Fig. 9;

Fig. 13 is a flowchart illustrating procedures taken during warming and thawing of a cryopreserved biological sample using the system of Fig. 9; and

Fig. 14 is a flowchart illustrating procedures taken during cryopreservation and subsequent warming and thawing of a biological sample using the systems of Figs. 1-13.

DETAILED DESCRIPTION

The present invention provides systems and methods for cryopreservation of biological samples. Such systems are illustrated in Figures 1 -8. The present invention also provides systems and methods of warming/thawing, reconstituting and/or rehydrating a biological sample that underwent vitrification. Such systems are shown in Figures 9-13. The cryopreserved or vitrified biological sample could be a sample cryopreserved by the systems/methods of Figures 1-8. Alternatively the cryopreserved sample can be a sample cryopreserved by use of another system/method. Thus, the vitrification system/methods disclosed herein and the warming, thawing, and reconstituting systems/methods disclosed here can be used independent of one another. However, the present invention also contemplates a complete system/method that provides for both cryopreservation of a biological sample of any of the embodiments of Figures 1-8 (and their described alternatives) and subsequent warming, thawing, and reconstituting, of such cryopreserved sample utilizing any of the embodiments of Figs. 9-13 (and their disclosed alternatives). The combined system is reflected in the flow chart of Fig. 14. Each of the systems is discussed in detail below.

Throughout the present disclosure, the terms "warming," "thawing," "cooling," and "reconstituting," as well as variations thereof, may be used collectively or interchangeably. It should be understood, however, that each of these terms are used in connection with a single process by which a cryopreserved biological sample is returned to its natural state, i.e. , its state prior to cryopreservation, or a state that closely approximates the natural state of the sample.

Moreover, through the present disclosure, when used in connection with empirical values, e.g., volumes, dimensions, etc.. the terms "about" and "approximately" should be understood to modify the disclosed empirical values by ±25%, or more.

Referring now in detail to the drawings wherein like reference numerals identify similar or like components throughout the several views, and turning first to cryopreservation, an embodiment of the tube is designated by reference numeral 100 in Fig. 1 and an embodiment of the pod (capsule) is designated by reference numeral 200 in Fig. 2a. These two components are coupled together as described in detail below to retain the biological sample within the tube. Note that Figure 1 illustrates one exemplary embodiment of the tube of the present invention and Figure 2a illustrates one exemplary embodiment of the pod of the present invention, as other configurations are also contemplated as will become apparent from the discussion below. In addition, unless specifically noted otherwise, embodiments described or referenced in the present description can be additional and/or alternative to any other embodiment described or referenced therein.

The components/system of the invention described herein are configured to vitrify at least one biological sample, i.e., either a single sample or multiple samples. However, for simplicity the system described herein refers to "a sample". It should be understood, that unless specifically noted otherwise, whenever "a sample" is used the same also applies to "at least one sample". Similarly, whenever reference is made to "the sample", the same should apply to "the at least one sample" as well. Thus, the system can be used to vitrify one or more samples within the tube, with only one shown in the drawings for ease of understanding.

Turning now to Fig. 1 , a perspective view of one embodiment of a tube of the present invention is illustrated. Tube 100, also referred to herein as a straw, is a capillary device configured to apply cryoprocedures to a biological sample 102 contained within the tube. Capillary device 100 may be composed of transparent, translucent and/or opaque members. Accordingly, biological sample 102 that resides inside the capillary device 100 may be visible from outside the device 100, or alternatively, not visible from the outside, In Fig. 1 , the tube 100 is transparent so the biological sample is visible. This aids explanation of the invention.

The tube (capillary device) 100, also referred to herein a tubular member, has a lumen formed therein forming a capillary duct 108 extending from a proximal end 106 to a distal end 104 of the device. At the distal end 104, a perforated member 1 10 is illustrated. This perforated member 1 10 is part of the pod which is inserted into the tube 100 and discussed in detail below. Note that the perforated member 1 10 in this embodiment is retained by a pod that fully sits within the tube 100 so it is positioned at the distalmost portion substantial flush with the distal edge 107 of the tube 100. Alternatively, it can be positioned proximal of the edge 107. In any event, it functions to allow inflow of liquid and prevent exit of the biological sample 102 from the tube 100. Note in the embodiment of Fig. 1 , the pod does not have a flange as in Fig. 2a so that the pod is fully inserted within the tube 100. At the proximal end of the tube 100, a manual pump 1 12 is provided. This manual pump 12 is utilized to pump liquid through the tube 100 which is described in more detail below. It should be appreciated that the manual pump 1 12 is optional and in some embodiments it is not provided. Moreover, while the pump illustrated in the figure is one type of manual pump that can be utilized, other manual pumps can also be utilized. Additionally, it should also be appreciated that in other embodiments, pumps other than manual pumps can be utilized to pump liquid such as an electrical pump. Thus, the present invention is not limited to the manual pump shown as other ways to pump liquid can be utilized. Inside the capillary device 100 there is lumen creating a free space 104, constituting a "capillary space". Similar to the capillary duct, the capillary space also has a distal end (at the capillary duct's distal end) and a proximal end (at the capillary duct's proximal end) as it extends along the length of the device 100,

The tube 100 in some embodiments has a length ranging from about 100mm to about 130 mm, however, other lengths are also contemplated. The tube 100 in some embodiments has an outer diameter ranging from about from about .3 mm to about 6 mm, and in some embodiments from about 1.5 mm to about 6mm, an inner diameter ranging from about .1 mm to about 5.8 or about 1.5 mm to about 5.8 as the wall thickness can be about .2 mm. Note that these dimensions are provided by way of example and should not be considered as limiting as other dimensions (wall thickness, diameter, length, etc.) to achieve the functions of the tube described herein are also contemplated.

Cryoprocedures, with reference to some embodiments described herein, comprise culturing, vitrification, and/or cryopreservation. In some embodiments, a cryoprocedure may be any one of culturing, vitrification, freezing, lyophilization, and/or cryopreservation. In some embodiments cryoprocedures may comprise vitrification and cryopreservation, with or without culturing. In some embodiments the systems of the present invention can be used for the procedures of thawing and/or warming after cryopreservation. The description herein generally refers to vitrification as an example of a cryoprocedure. However, it should be appreciated that other cryoprocedures referred to herein can be, e.g., any one of the cryoprocedures mentioned above. The devices/systems disclosed herein can also be used for procedures other than the foregoing. The biological sample 102, shortly referred to as sample", may be of an animal origin, including but not restricted to human beings, mammals, and vertebrates. In some cases, the biological sample may be a single cell sample, such as an oocyte or sperms, while in other cases, the biological sample may be a multi-cell suspension. In yet other cases, the biological sample may be a tissue, for example a piece of tissue, such as a slice of ovarian tissue or a slice of testicular tissue, an embryo, or others. In some cases, the invention is used for handling reproductive biological samples (such as oocytes and/or sperm and/or embryos and/or ovarian tissues and/or testicular tissue etc.). However, the invention is not limited to reproductive biological samples and embodiments thereof may be directed to other kinds of biological samples. One non limiting example for using the invention with other (non-reproductive) kinds of biological samples is preparing a piece of tissue taken in a biopsy for cryopreservation, before the piece is sent for analysis.

The biological sample can be loaded into the capillary space of the capillary duct of the tube (straw) using different methods. It is well known that capillarity (known also as capillary action or capillary motion) gives rise to the ability of a liquid to flow in narrow spaces without the assistance of, or even in opposition to, external forces such as gravity. Accordingly, the mass of the biological sample affects the ability to load it into the capillary duct by capillary action. For small biological samples the loading of the cells may take place via capillary action. For larger biological samples, loading may take place using a pump such as pump 1 12 of Fig. 1 to pump-in the sample. If applicable, a pump can be used also for loading small biological samples. It is known that the determination of a sample being small or large so as to allow or prevent its capillary loading is effected, e.g. , by the radius of the capillary space, the mass of the liquid and the mass of the sample.

Turning now to the pod of the present invention, also referred to herein as a capsule, container, retainer, or retaining member/element, and with initial reference to Fig. 2a and Fig. 2b, the pod is designated generally by reference numeral 200. While in Fig. 2a the whole pod is illustrated, Fig. 2b presents a cutaway view of the pod 200 to explain/illustrate features of the pod 200. Pod 200 includes a perforated member or portion 1 10 mounted therein. The perforated member 1 10 can be composed of a membrane or mesh material, although other materials are also contemplated to provide openings (orifices). The perforated member 1 10 has at least one orifice 202, and in certain embodiments, a plurality of orifices, the diameter of each orifice being small enough to prevent the biological sample 102 from flowing (exiting) therethrough, i.e., the diameter (or transverse dimension) of the orifice is smaller than the diameter (or transverse dimension) of the biological sample 102, therefore functioning as a restriction or restricting element for the sample. However, the diameter of the orifice is large enough to allow inflow of selected fluids. It should be understood that a biological sample flowing through an orifice actually outflows from the pod, and in most cases this means that the sample is lost. Therefore, the orifice diameter or dimension is provided to be less than the diameter or dimension of the sample. As can be appreciated, the use of the term "diameter" is used to describe the transverse dimension of the orifice and sample and is not limited to a circular dimension since the orifice or sample need not be circular. Therefore, the term diameter can be considered to denote a transverse dimension of the orifice or sample, e.g., a length from one end to the other. By keeping the transverse dimension of the orifice smaller than the sample, the sample is prevented from flowing through the orifice. In certain specific embodiments, all of the orifices have such transverse dimensions smaller than the transverse dimension of the sample. For example, in some embodiments the diameter of an orifice 202 does not exceed 5 μιη (micrometer) or ΙΟμι^η or 15μπι or 20μιτι or 25μηι or 40μιτι or 50μηι or 55μπι or 60μηι or 65μπι or 70μηι or 75μπι or 80μηι or 85μπι or 90μηι or 95μηι or ΙΟΟμηι or 120μηι or 140μπι or 150μπι or Ι όθμηι or 180μ^ηι or 200μηι or 250μπι or 300μηι or 350μηι or 400μιη or 450μηι or 500μπι or another diameter configured to be smaller than the diameter of the biological sample. Note these are provided by way of example as other dimensions are also contemplated. Also, the dimensions of the orifice can be selected to correspond to the type of biological sample, e.g. , smaller samples requiring smaller orifices.

It should be appreciated that in certain specific embodiments, multiple biological samples are contained within the tube 100 and are retained by the perforated member 1 10, however, only one sample is shown in the drawings for ease of illustration.

It is noted that "at least one orifice" covers the case wherein the perforated member comprises a single orifice, as well as those cases when the perforated member comprises multiple orifices. Also, although shown as round, the orifices can be other shapes, such as rectangular as shown for example in the embodiment of Fig. 2e described below.

Pod 200 includes a flange or base 201 and a circumferential wall 204 extending therefrom, the wall 204 delineating a holding space 206 in the pod 200 in which a portion of the tube containing the biological sample 102 may reside. In alternate embodiments, the pod would not include a flange and would therefore be fully inserted into the tube 100 as shown for example in the embodiment of Fig. 1. The illustrated embodiments of pod 200 have a circular cross section and circumferential wall 204 also has a circular cross section. However, this is provided by way of example as the circumferential wall (and the pod itself) may have a different shape such as a polygonal cross section of circumferential wall 208, as illustrated in Fig. 2c. Circumferential wall 208 could be for example a rectangular circumferential wall, a square circumferential wall, a pentagonal circumferential wall or any other basic/classic cross sections of circumferential wall. It could also be non-basic/non-classic shapes or asymmetric. Thus, as can be appreciated, various shapes of the pod and circumferential wall are contemplated and are applicable to any of the embodiments described herein. Thus, the pods and circumferential wall can comprise any of the aforementioned cross sections or other shapes/configurations if applicable.

A cut in perforated member (member) 1 10 is illustrated in Fig. 2b, wherein the cut exposes longitudinal cuts 202a in three orifices 202. The longitudinal cuts illustrate that orifices 202 actually cross perforated member 1 10, i.e., extend through the thickness 205 (height), thereby allowing passage across the perforated member of particles whose diameter (dimension) is smaller than the diameter (dimension) of the perforations.

Furthermore, Figs. 2a, 2b and 2c illustrate orifices 202 with circular cross sections. As discussed above, this is just one example of orifices as other forms/shapes/configurations of orifices may be used if applicable. For example, it should be appreciated that under certain conditions, such as negative pressure, biological samples 102, such as oocytes, may be pulled, inside holding space 206 (or holding space 206' of Fig. 2c), towards perforated member 1 10. Under such conditions the biological sample may tend to penetrate the orifices, e.g., as illustrated in Fig. 2d. One object of the present invention, in some embodiments, is to improve sample recovery rates further to thawing or warming the sample after cryopreservation, however, such penetration of the sample into an orifice deteriorates its survival and recovery rates. Therefore, for certain applications, it may be desirable to provide alternative orifice configurations as described above. One such alternative configuration is illustrated in Fig. 2f, where the orifices 210 have a square (or substantially square) cross section. In certain applications, the square cross section reduces the tendency of the biological sample to penetrate into the orifice. Fig. 2f is a drawing of the entire pod 21 1 of Fig. 2e having perforated member 1 10' with square orifices 210. Note perforated member 1 10' is identical to perforated member 1 10 except for the shape of the orifices.

As noted above, it should be appreciated that the forms of orifices described thus far (round and square) are non-limiting and other orifices having different forms and shapes may be provided. For example, an orifice may be a slit through which capillary flow may appear.

So far, in the embodiments depicted in Figs. 2a-2f, the circumferential walls of the pods are perpendicular or substantially perpendicular to the perforated member (and the base 201) meaning that the two surfaces (the perforated member and the walls) meet at a right angle (90 degrees) or a substantially right angle meaning for example a deviation of about 1 to about 3 degrees, e.g., due to minor shape distortions. It is noted that substantial perpendicularity is non- limiting and in other embodiments the perforated member and the walls may meet at an angle wider (larger) or narrower (smaller) than 90 degrees. Moreover, the angle may change along the walls. The meeting angle a of the perforated member and the circumferential wall 204 is measured inside the pod's holding space 206 and is marked as angle a. In those cases where the angle of the circumferential wall changes along the lines there would be at least one position along the walls wherein the meeting angle, marked as β, would be different than angle a, i.e., β≠ a. Accordingly, Figs. 2g, 2h and 2i schematically illustrate two-dimensional representations of pods, according to embodiments of the invention, with different angling circumferential walls 204, wherein in Fig. 2g a < 90 degrees such as about 80 degrees; in Fig. 2h a > 90 degrees, such as about 100 degrees; and in Fig. 2 α≠ β such that a is about 80 degrees and β is about 95 degrees. As can be appreciated, these dimensions are provided by way of example for illustrative purposes and other angles are also contemplated.

Measuring the meeting angles a and β inside the pod's holding space is a matter of convention, however, in some embodiments, the angles are measured externally to the holding space.

It is possible to select any point along the upper rim of the circumferential wall and draw on the circumferential wall the shortest line from the selected point to the perforated member. Such a line constitutes a "height". In the embodiments described so far with reference to Figs. 2a-2i, the heights are straight lines. In some embodiments, the circumferential walls of the pod may be bent or curved instead of straight. One example of a bent circumferential wall is shown in Fig. 2, wherein the walls bend towards the center, i.e. , toward a longitudinal axis of the pod, as they extend proximally in a direction away from the perforated member. Other bends or nonlinear walls are also contemplated.

It should be appreciated that in some embodiments, e.g. , as illustrated in Fig. 2, the perforated member may form a non-planar base. The non-planar base can have arcuate portions or linear portions lying in different planes. Fig 2j provides an example where the perforated member has curved surfaces.

It should be appreciated that any combinations of the features of the aforementioned embodiments can be provided. That is, the shape of the orifices, the shape of the circumferential wall, the angle of the circumferential wall, the linear or non-linear feature of the circumferential wall, and/or the planar or non-planar feature of the perforated member, etc. can be utilized to form the pod. By way of example, the circular walls of Fig. 2a can be combined with the square orifices of Fig. 2e and/or the non-planar perforated member of Fig. 2j. Any other combination may apply as well, including a circumferential wall having different shapes for its side facing the holding space and the outer side.

The circumferential wall of the pod in some embodiments has an inner diameter of about 1.4 mm to about 5.7, and an outer diameter ranging of about 1.5 mm to about 5.8. In certain specific embodiments, the wall has a thickness of about .1 mm to provide a thin wall to provide very high heat transfer during cooling and warming. Note that these dimensions are provided by way of example as other dimensions to achieve the functions of the pod described herein are also contemplated. The dimensions of the pod 200 and the tube 100 are related for the reasons described below for coupling these two components, i.e. , placing one inside the other. The pod can be made of various materials, and one contemplated material is polycarbonate.

It should be appreciated that generally the pod can be considered comprising a vessel (or vessel portion) and a holding space. The vessel, according to some embodiments, comprises the circumferential wall (and the base or flange if provided) and the perforated member. The vessel comprises at least one opening at its proximal end into the holding space and a plurality of orifices at its distal end communicating with the holding space. In certain specific embodiment, the size of the opening into the holding space is defined by the internal diameter of the circumferential wall.

The pod 200 can be coupled to the tube 100/capillary duct, such as capillary duct 108 of capillary device 100 of Fig. 1. That is, the capillary duct and the pod are structurally couplable/connectable. For example, Figs. 3a-3c illustrate coupling of pod 200 of Fig. 2a with tube 100/capillary duct 108 of Figure 1 by way of example. The pod and tube of other embodiments described herein can be coupled in the same manner. Note the pod 200 and capillary duct 108 are shown as cutaway views in Figs 3a-3c for ease of explanation. The distal end 104 of the capillary duct 108 which has a distal opening approaches the circumferential wall 204 of pod 200. In order to couple the pod with the capillary duct, the external form of circumferential wall 204 adapts/conforms to the internal form of the capillary duct at and close to the duct's distal opening, similar to the adaptation of a key to a keyhole. In Fig. 3a, the capillary duct 108 is approaching the proximal end of the pod 200 at the opening in the circumferential wall 204 to the internal space; in FigJb the capillary duct 108 further approaches the circumferential wall and is shown positioned partially over the circumferential wall 204. In Fig. 3c the capillary duct 108 is fully inserted over the circumferential wall 204, abutting base 201. Coupling is achieved when the pod 200 and tube 100 are locked/secured together, i.e. , the pod 100 locks the capillary duct 108 and/or vice versa (i.e. , the capillary duct 108 locks the pod 100). In some embodiments the locking is achieved by the frictional engagement of the two components due to the outer diameter of the circumferential wall 204 of pod 200 closely matching, but slightly less than, the internal wall diameter of the tube 100. The frictional engagement can be enhanced by shrinkage at low temperatures to provide an increased pressure coupling as described in detail below. As a result of the coupling, the holding space of the pod 200 and the capillary space of the capillary duct 108 together form a preparation space in which a liquid column may be formed. In some embodiments, the pod can be manufactured with the capillary duct, as a single unit, wherein the sample may be loaded into the preparation space, e.g., from the proximal end of the capillary duct/space.

Alternative ways to couple the pod and tube (capillary duct) are also contemplated. For example, instead of coupling the capillary duct to the pod by pressure or by frictional engagement, they can be provided with a respective internal and external screw thread so they can be attached by screwing the components together. As shown, the capillary duct 108 is moved into engagement with the pod 200, however, it is also contemplated that the pod 200 is moved into engagement with the capillary duct 108 or both are moved toward each other into engagement for coupling.

In accordance with another alternate embodiment, the pod and tubes can be configured so that the capillary duct 108 fits into the pod 200 and is secured by pressure or frictional engagement rather than the pod fitting into the capillary duct as shown in Figs 3a-3c. In such embodiments, the internal diameter of the pod 200 would be close to, but slightly greater than, the external diameter of the capillary duct 108 so that the pod 200 would be fitted over, i.e., external to, the capillary duct 108 and retained for example by a frictional fit or retained by being screwed together in embodiments wherein an external thread is provided on the tube 100 and an internal thread is provided on the circumferential wall of the pod 200. Thus, in this alternate embodiment, they can be coupled by pressure or a frictional fit as the capillary duct fits into the pod, and such coupling can be utilized with any of the pod and tube embodiments disclosed herein. Other alternative ways to couple the two components (members) can be utilized, as long as the result is a preparation space obtained by coupling a pod with a perforated member to the tube, e.g., capillary duct. In those cases wherein the pod fits into the capillary duct or the capillary duct fits into the pod, it should be appreciated that there is an element (component or member) that is a hugged internal element and an element (component or member) that is a hugging (external) element (component or member). When the pod fits into the capillary duct, it is the capillary duct that is external and hugs the pod as the pod is internal and being hugged by the duct. Conversely, when the capillary duct fits into the pod, the pod is the external hugging element while the duct is the internal hugged element. It is known that in low temperature, different materials display different degrees of shrinkage. Therefore, in order to prevent disintegration of the duct-pod connection in low temperature settings, the hugging element needs to be made of material with higher shrinking coefficient compared to the hugged element. For example, if the capillary duct is the hugging element which is manufactured of polypropylene, the pod can be made of polycarbonate. Other materials are also contemplated to ensure that the internal hugged element does not shrink to a greater degree than the external hugging element which could loosen or disengage the coupling which was formed by a tight fit between the two components. Also, this shrinkage characteristic can be used to provide a pressure fit as the external component would shrink to further hug (clamp) the internal component. Note the pressure fit can be provided to enhance the frictional engagement or relied on for coupling without the frictional engagement.

Methods for using the devices of the present invention for cryopreservation of a biological sample will now be described. The methods described herein advantageously enable multiple samples, e.g., eggs, if desired, to be retained in the pod and placed in solutions as a group rather than requiring individual samples, e.g. , eggs, to be moved one by one into the various solutions. Additionally, due to the coupling of the tube and pod, a larger number of biological samples can advantageously be retained by the tube. The procedure provides a simple, fast and efficient method of cryopreservation. Note, the method of the present invention can also be used for a single biological sample, also providing the foregoing advantages.

It should be appreciated that due to capillarity, when the distal end of the capillary duct (such as distal end 104 of capillary duct 108 in Fig. 1) is immersed in a liquid, the capillary space will draw the liquid up (toward the proximal end 106 if the proximal end is open), giving rise to a liquid column. Herein the term "immersing" means bringing the distal end in touch with a liquid, so as to allow capillary action to build a liquid column in the capillary duct. On the other hand, it is also possible to drain liquids from within the capillary space of the capillary duct. Draining can be done for example by bringing the distal end in touch with a material having adhesion which is strong enough to overcome the adhesion forces operating in the capillary space to hold the liquid column to drain the liquid out the distal end. For example, it is possible to drain the liquid with a blotting paper or even with an absorbent cottonwool or cotton. Alternatively, instead of draining the capillary duct with an absorbent material, it is possible to push the liquid out of the capillary duct distal end by using, for example, a pump coupled to the duct's proximal end such as the manual or other pumps described herein.

It has been explained above that the biological sample can be loaded into the capillary duct, for example, by capillary action. In addition, it is known in the art that the process of vitrification involves changes of solutions in which the sample should be submerged. Fig. 4 presents a flowchart illustrating procedures taken in order to prepare a sample for vitrification, according to one method of the present invention. Thus, the system and method of utilizing the device (coupled pod and tube) can be appreciated with reference to the flow chart of Fig. 4. The method refers to use of the tube 100 of Fig. 1 and the pod 200 of Fig 2a, it being understood, however, that other embodiments of the tube and pods can be utilized and the method of Fig. 4 is fully applicable to these other embodiments.

In step/box 402, a sample is loaded into a capillary space of a capillary duct (e.g., duct 108 of tube 100 of Fig. 1). As was previously explained, loading into the duct can be done, for example, by capillary action or by using a pump such as pump 1 12 of Fig. 1. It should be noted that immediately after loading into the capillary duct 108, the sample resides inside the capillaiy space, submerged in a liquid that is similar to the liquid in which it was submerged prior to loading. Hence, for example, had the sample been stored in a holding medium prior to loading, then immediately after loading the sample would be submerged in the holding medium inside the capillary space. Note the method as described herein refers to "the capillary duct" for convenience as way of example, it being understood that this refers to the internal lumen or "duct" of the tube 100 which exhibits capillarity. Thus, if a pump is used, the sample would be submerged in the holding medium in the duct or lumen of the tube as used herein, if the tube is not so configured to achieve a capillary effect. Consequently, unless otherwise noted, the method of Fig. 4 and Fig. 6 (and Fig. 14) would be applicable to a non-capillary duct, except for the first step where the sample would be loaded into the tube in another way.

In step 404, a pod, such as pod 200, is coupled to the distal end of the capillary duct, such as duct 108. Coupling is performed by the ways described herein, such as by applying pressure (see Figs. 3a-3c), by screwing etc. Note the perforated member 1 10 of the pod 200 prevents the sample from unintentionally running out of the capillary space through the distal end of the capillary duct.

It is understood by those versed in the art of vitrification that in order to prepare a biological sample for vitrification the sample needs to be submerged in a series of solutions that gradually replace the water that naturally resides in the sample with cryoprotectants. In the example of vitrification, these are known as a holding medium (HM), equilibration solution (ES) and vitrification solution (VS). A holding medium can be buffer solution supplement with proteins, equilibration solution could be 7.5V/V Dimethyl sulfoxide (DMSO), 7.5%V/V Ethylene glycol (EG) and 20% fetal calf serum (FCS) in buffer solution. Vitrification solution can be 15%V/V DMSO, 15%V/V EG, 0.5M sucrose and 20% fetal calf serum (FCS) in buffer solution. Accordingly, for each solution in the series, the liquid within the capillary space is drained (step 406), e.g. by touching with the distal end on a blotting paper, filter paper, absorbent cottonwool or cotton etc., as was previously explained, and in step 408 the next solution in the series is loaded into the capillary space by immersing the distal end therein. After the last solution is drained in step 406 the capillary duct can be inserted in step 410 into e.g., liquid nitrogen, liquid nitrogen slush or liquid air for cryopreservation. Capillary force if provided will keep the solution in the straw. Note in some embodiments, before plunging into liquid nitrogen the straw can be evacuated.

Therefore, embodiments of the invention disclose a device (such as device 100) that is configured to treat the biological sample with a series of solutions. The series may comprise any applicable number (n) of solutions, such that n=l , n=2, n=3, n=4, n=5, 5=6, n=7, n=8, n=9, n=10, or any other applicable number of solutions as appropriate to the case. In addition, it should be understood that the flowchart of Fig. 4 is disclosed by way of example only, and other embodiments may exist. For example, the device comprising tube (straw) 100 of Fig. 1 , with any applicable pod (see, e.g., Figs. 2a to 2k), is configured to be used for preparation of a biological sample for cryopreservation as well as for cryopreservation itself, as it can be inserted into liquid nitrogen. However, alternative methods to those presented in Fig. 4 may skip step 410 ("insert into liquid nitrogen"). For example, instead of cryopreserving the sample while inside the device, it is possible to extract it from the capillary space, transfer it to another container or tool for insertion into liquid nitrogen, i.e., by placing it in a cryo carrier such as, for example, Cryotop®, Cryotech, Cryoleaf™, Cryolock™, Rapid-i™, Vitrifit, a Cryo Bio System (CBS) carrier, etc.

Further to understanding the embodiments described so far, it can be appreciated that solutions can be loaded into the capillary space by additional or alternative ways to capillarity action. For example, according to some embodiments it is possible to connect a pump to the proximal end of the capillary duct such as pump 106 of Fig. 1 , thus pumping the solution into the capillary duct instead of letting it flow in by capillary action alone. Moreover, understanding that the solution (or generally, the liquid) flows into the capillary duct by the force affected by the pump, it can be appreciated that in some embodiments the capillary duct is not capillary anymore. That is, embodiments of the invention comprise a "straw" or a "tube", wherein a "capillary duct" is a specific case (version) of a straw or tube. Similarly, a "straw space" or "tube space" is the space inside the straw or tube, while "capillary space" is a specific case (version) of a straw space or tube space that exhibits capillarity.

It is noted that all the embodiments previously presented with reference to devices comprising a capillary duct apply also to devices comprising a straw or tube that does not have/utilize a capillary duct. This includes also the various embodiments of the pods which can be coupled to the straw or tube. Accordingly, the embodiments presented with reference to Figs. 1 , 2a to 2k and 3 also apply to a non-capillary straw or tube. According to a method that is an alternative to the method of Fig. 4, it may not be required to drain the liquid from the straw space prior to loading the next liquid thereto. This could be applicable when a pump is coupled to a straw or tube in order to draw liquid into the straw space or tube space. In certain embodiments, the second liquid (for example, equilibration solutions) has a density that is higher than the density of the first liquid (for example, holding medium), the third liquid (such as vitrification solution) has a higher density compared to the second liquid and so forth (series has higher density compared to its preceding density, in other words, it is heavier). It may be understood that having a layer of a solution above a layer of previous solution in the straw space would not result in mixing thereof, at least not without investment of additional energy, such as by mixing. In other words, liquids of successive increased densities are sequentially/progressively inserted into the straw (tube) and do not mix. Fig. 5 illustrates a straw 500, similar to straw (tube) 100, having four different layers therein, marked as 502, 504, 506 and 508. As noted above, element 500 is in the form of a tube and is explained herein as constituting a straw, a type of tube. The straw distal end is labeled with reference numeral 510 and the straw proximal end is labeled with reference numeral 512. In the distal end there is a perforated member 514 that can be, for example, the perforated member of any one of the pods described with reference to Figs. 2a- 2k. Straw 500 can be capillary or not capillary, as applicable to the case as described above. It can be appreciated that layer 502 is the heaviest solution (in terms of density), 504 is lighter, 506 is even lighter, and the lightest is solution 508. A pump 516, shown schematically, can be disposed at the proximal end 512 and can be in any of the forms described above and functions as described above. Reference numeral 518 represents a biological sample contained within the straw 500 and reference numeral 520 represents the straw space, e.g. lumen within the straw 500.

Note in Fig. 5 and Figs. 7a-8c, a version of the pod is shown which does not have the flange (lip base) so it is fully contained within the straw 500. Clearly, pods with flanges could also be utilized in which the flange protrudes from a distal end of the straw as in Fig. 3c.

Fig. 6 is a flowchart illustrating procedures taken in order to prepare a sample for vitrification, according to an alternate embodiment of the invention which does not require draining as in Fig. 4. That is, the method of Fig. 6 resembles the method of Fig. 4, except no draining is performed among the loadings of the different solutions. In step/box 602, a sample 502 is loaded into a straw space 520 (or space 1 14) of an empty straw (e.g. 100 or 500). As was previously explained, loading can be done, for example, by capillary action in a capillary duct or by using a pump (such as pump 1 12 or 516 or alternative pumps described herein). It should be noted that immediately after loading, the sample resides inside the straw space, submerged in a liquid that is similar to the liquid in which it was submerged prior to loading. Hence, for example, had the sample been stored in a holding medium prior to loading, then immediately after loading, in certain specific embodiments, there would be a sample submerged in the holding medium inside the straw. This is also the case in the method of Figure 4.

In step 604 a pod is coupled to the distal end of the capillary duct. Coupling is performed by any way applicable to the case, such as by friction, applying pressure (see e.g., Figs. 3a-3c), by screwing etc., or alternate methods. The perforated member of the pod would prevent the sample from unintentional running out of the capillary space via the distal end of the capillary duct.

It has been noted before that those versed in the art of vitrification would appreciate that in order to prepare a biological sample for vitrification the sample needs to be submerged in a series of solutions, with the densities of the solutions increasing as the preparation advances, because the concentration of cryoprotectants increases. Accordingly, for each solution in the series, in step 608 the next solution in the series is loaded into the capillary space by immersing the distal end therein and operating the pump. Finally, all the layers are drained in step 610 and the straw can be inserted in step 612 into liquid nitrogen, liquid nitrogen slush or liquid air for cryopreservation.

Figs. 7a, 7b and 7c illustrate stages of loading the straw 500 of Fig. 5, according to the method set forth in the flow chart of Fig. 6 (and Fig. 4). The same stages may occur with the capillary duct of tube 100 of Fig. 1 or other tubes when it has a pump coupled thereto to pump liquid. In can also be in some embodiments with a tube having a capillary effect. In Fig. 7a, the first layer 508 is loaded with the biological sample 518. In the described example of preparing the sample for vitrification, the first layer may be of a holding medium. Then, in Fig. 7, a second layer 506 is loaded as well which can be achieved by placement of the pod in the solution. Layer 506 in the example is a holding solution whose density is higher than that of the holding medium and hence layer 508 is "pushed up" thereby (moved proximally) and layer 506 appears below (distal of layer 508). It is advised to avoid shaking the straw, or the layers may mix. In addition, the biological sample gradually absorbs the holding solution, which replaces the holding medium that has been there before. This turns the sample heavier and therefore it sinks from layer 508 to layer 506, moving toward the bottom of the straw (at the distal end). Thereafter, because there are other, unloaded solutions in the series, the process repeats itself as the straw and pod are moved to another solution and layer 504 is loaded into the straw, as illustrated in Fig. 7c. Layer 504 may be equilibrium solution. It is heavier than the holding solution of layer 506, and therefore layers 506 and 508 are pushed up (proximally) and layer 504 resides therebelow. Sample 518, which absorbs the equilibrium solution, further sinks to layer 504, moving to the distal end. Finally, a fourth solution (such as a vitrification solution) in the present example is loaded, and this yields Fig. 5, wherein layer 502 comprises the fourth, heaviest solution and biological sample 518 sinks again to the distal end (bottom) as it absorbs the solution. The fourth solution may be another equilibrium solution, heavier than that of layer 504.

It is noted that the description above does not intend to teach how to perform vitrification. Rather it is intended to disclose how to use the straw of the present invention in order to prepare the sample for vitrification. Therefore, the procedure described does not intend to be an accurate vitrification procedure. Further to reading the procedure described herein, a person versed in the art of vitrification will be able to apply the procedure to a known vitrification process.

Another alternate method for preparing a sample is disclosed in Figure 8, applicable to the method of Fig. 6 and Fig. 4, which does not necessarily require either capillarity or the usage of a pump, and utilizes the concept of communicating vessels. When a tube, open at both ends, is immersed in a container with a liquid, the liquid would fill the tube to a level similar to the level of the liquid in the container.

Figs. 8a-8d illustrates loading four solutions into a straw, according to embodiments of the invention. In Fig. 8a, a straw (or tube) 800 is immersed in a first solution within a container 802 in order to load a biological sample 804 into the straw 800. Straw 800 is coupled at a distal end to a pod with a perforated member as described in the various embodiments above. The level of the solution in container 802 is marked by line 806. If the procedure is for preparation of a biological sample for vitrification, the first solution may be a holding medium in which the biological sample resides. In order to load the sample into the straw 800, a pump can be coupled to the proximal end thereof, and possibly disconnected after the loading. The pump is not illustrated in Figs. 8a-8d but as can be appreciated could resemble the manual pump 1 12 of Fig. 1 such as a bulb or an electric pump.

As can be seen in Fig. 8a, inside straw 800 there is obtained a layer 808 of the first solution, whose level is similar to the level of the solution in the container 802. Thereafter, the straw 800 can be removed from the first container 802 and transferred to a second container 810, holding a second solution, heavier than the first solution, whose level in the container, marked as 812, is higher than level 806 of the first solution in container 802. In response, the lighter layer 808 would be pushed up so as to equalize level with the liquid level 812, wherein a new layer 814, of the second solution, would reside therebelow (distal of layer 808). In addition, it is illustrated in the figure that biological sample 814 would sink from layer 808 to layer 814, as was previously explained with reference to Figs 7a-7c. Therefore, biological sample 814 is being treated by the second solution in the straw space.

It is noted that upon transferring straw 800 from container 802 to container 810, layer 808 of the first solution should be kept inside. If the straw is narrow enough to maintain capillarity, the layer will be kept inside. However, if the straw does not maintain capillarity, it may be required to seal its proximal end during the transfer, thus preventing loss of layer 808. This is relevant to any transfer of the straw 800 from one container to another. In small straws, e.g., 25 or .5 ml, a seal might not be necessary. In larger straws, the proximal end can be blocked with the finger if a seal is desired.

Subsequently, straw 800 is removed from container 810 and transferred to container 816, holding an even heavier third solution, whose level 818 is higher than level 812 of the second solution in container 810. Again, the two previous layers (808 and 814) are pushed up (proximally) by the third solution to equalize the level inside the straw to level 818 of the third solution. Thus, layer 820 of the third solution is created below (distal of) layers 808 and 814, while sample 804 sinks thereto into the layer 820. Therefore, biological sample 814 is being treated by the third solution in the straw space.

Finally in the present example, straw 800 is transferred from container 816 to container 822, holding a fourth, heaviest solution, whose level in the container, marked as 824, is higher than level 818 of the third solution in container 816. In response, layers 808, 814 and 820 are pushed up (proximally) by the fourth solution to equalize the level inside straw 800 to level 824 of the fourth solution. Thus, layer 826 of the fourth solution is created below (distal of) layers 808, 814 and 820, while sample 804 further sinks thereto into layer 826. Therefore, biological sample 814 is being treated by the fourth solution in the straw space.

It should be understood that the invention is not limited to four layers of four solutions, and the four layers of the various methods are provided by way of example. The number of layers and solutions may vary as required, and it can be for example one layer and solution, two layers and solutions, three layers and solutions, four layers and solutions, five layers and solutions, six layers and solutions, seven layers and solutions, eight layers and solutions, nine layers and solutions, ten layers and solutions, or any other number of layers and solutions applicable to the case. Generally, the device is configured to treat the biological sample with a series of solutions whose density increases gradually or gradually gets heavier. This progressive increase moves the previous layer upwardly (proximally) within the straw as the sample sinks to the lowest higher density level.

In addition, in the Figures, containers 802, 810, 816 and 822 are shown schematically as similar containers. However, due to the communicating vessels concept, the level of liquid in the straw would become the same as the level of liquid in the container where it is immersed, regardless of the shape and volume of the containers. Thus, different shape containers with different volumes can be utilized.

Moreover, while in the example the level of the solution in the containers gets higher as the process advances, it should be understood that this is non-mandatory as well. Instead, it is possible to keep the level constant or even lower it, as long as the straw is immersed deeper and deeper in the solution. Hence, generally speaking, any manipulation allowing rise of the level of solution in the straw space in accordance with the communicating vessels concept may be applied, including combinations {e.g., for the second layer increase the volume, for the third layer immerse deeper, etc., as applicable to the case).

Further to understanding how the communicating vessels concept can be applied by some embodiments of the invention, other embodiments are described. In these embodiments, it is possible to fill the straw space with a layer of solution, then close the proximal end of the straw space. Next, if the straw is transferred to another solution (or if the solution in the container changes to another solution), it should be appreciated that the composition of the solution in the layer, or at least in its bottom, near the distal end, will gradually change by diffusion.

While embodiments presented so far referred to gradually increasing densities, it should be appreciated that this is not always the case and sometimes the densities may be gradually decreased instead of increased. One such example is while warming or thawing a vitrified biological sample in accordance with the method described below. In such an example, there is a need to gradually reduce the concentration of cryoprotectants around and within the sample. In some embodiments, a high concentration of sucrose (e.g., a 1 M, 1 Molar sucrose solution) is used to dilute the vitrification solution in the straw space, thereby diluting the vitrification solution. Thereafter, the solution is further diluted by a lower concentration sucrose solution, such as 0.5M and so on. Thus, the devices and methods described herein can also be utilized to warm more a biological sample.

It can be understood that sometimes the densities may be decreased rather than increased in the different embodiments of the invention, i.e., those involving change of solution (see, e.g., Fig. 4), those involving diffusion of solutions, and those involving layers of solutions (see, e.g., Figs. 5, 6, 7a-7c and 8a-8c) that is, as generally explained, the biological sample loaded into the straw space is gradually exposed to solutions having gradually changing densities. The perforated member prevents loss of the sample, while it still allows in-flow and out-flow of the solutions therethrough (solutions are kinds of liquids). The methods described herein are conducted manually step by step. It is also contemplated, that the movement of the device into different solutions can be automated and performed by a robotic arm. The step of inserting the device into liquid nitrogen can also be performed robotically instead of manually as described above.

Warming. Thawing, and Reconstitution System

With reference now to Figs. 9-12, a system 1000 is disclosed for use in warming, thawing, and reconstituting a cryopreserved biological sample is disclosed. The system/method can used in connection with the aforedescribed biological sample 102 following cryopreservation by the systems/methods of Figs. 1 -8, or alternatively, can used for warming, thawing, and reconstituting a biological sample cryopreserved by another system/method.

The warming system 1000 includes a first system 1 100 that is configured and dimensioned to warm the biological sample 102 to a desired temperature, e.g., 37°C, and a second system 1200 that is configured and dimensioned to subsequently cool the warmed biological sample 102 to a desired temperature, e.g. , room temperature (22°C-24°C). While in one embodiment, both systems are provided, it is also contemplated that only one of the systems may be provided or utilized.

With particular reference to Fig. 10, the subsystem 1 100 includes a container 1 102 that accommodates both a cryogenic fluid 1 104, in which the cryopreserved biological sample 102 may be retained until warming/thawing, and a warming solution 1 106, separated from the cooling solution, which is used to restore and reconstitute the biological sample 102. In one particular embodiment, the cryogenic fluid 1 104 may include liquid nitrogen. It should be understood, however, that the cryogenic fluid 1 104 may include any solution, combination of solutions, compounds, etc. suitable for the intended purpose of maintaining the cryopreserved state of the biological sample 102 until warming, thawing, and reconstitution.

By accommodating both solutions 1 104 and 1 106 in close proximity, e.g., within about 3 cm to about 13 cm, and in one specific embodiment, about 3 cm, the container 1 102 reduces the time required to move the biological sample 102 from the cryogenic fluid 1 104 to the warming solution 1 106 which is preloaded in the straw 1004 when compared to known technologies, thus increasing the warming rate and increasing the efficacy of the procedure, as discussed in further detail below.

The cryogenic fluid 1 104 and the warming solution 1 106 are separated by an insulating wall 1 108, among other components, which creates an insulative barrier that minimizes, if not completely eliminates, any unwanted thermal transfer between the solutions 1 104, 1 106. The insulating wall 1 108, by way of example, defines a thickness in the range of about 0.5 cm to about 5 cm, and in one specific embodiment, about 3 cm. The insulating wall may include, e.g., be formed from, any material suitable for this intended purpose, such as, for example, Styrofoam or polymeric foams, or may be configured as two walls with a vacuum chamber therebetween.

The insulating wall 1 108 is configured and dimensioned to define an internal chamber 1 1 10 (Figs. 10, 12), and a receiving space 1 1 12 (Fig. 12). The cryogenic fluid 1 104 is retained within the internal chamber 1 1 10, and the warming solution 1 106 is retained within a holder 1 1 14 positioned within the receiving space 1 1 12. More specifically, in the embodiment illustrated in Figs. 10-12, the warming solution 1 106 is retained within a receptacle 11 16, e.g., a tube 1 1 18, that is configured and dimensioned for positioning within the holder 1 1 14. In the illustrated embodiment, to further facilitate placement and retention of the holder 1 1 14, the insulating wall 1 108 defines an inwardly extending shoulder 1 120 (Fig. 12) that provides a seat for a distal end of the holder 1 1 14. In the illustrated embodiment, the holder 1 1 14 is concentric with cylindrical insulating wall 1 102 and the cylindrical wall of the container 1 102, however, other arrangements and configurations are also contemplated

The receptacle 1 1 16 contains a predetermined volume of the warming solution 1 106, e.g., about .5 ml to about 5 ml of 1 M sucrose solution in the aforementioned holding medium. To maintain and control the temperature of the warming solution 1 106, in one embodiment, the holder 1 1 14 may include, or may be connected to, a temperature control unit 1 122 (Fig. 9). In the illustrated embodiment, the temperature control unit 1 122 communicates with a heating element 1 124 in the wall of the holder 1 1 14, which is in communication with a power source 1 126. To further increase the level of control over the temperature of the warming solution 1 106, the temperature control unit 1 122 may also include a programmable controller 1 128, as shown in Fig. 9, to regulate the amount of energy communicated to the warming solution 1 106. Although shown as being located internal to the holder 1 1 14 in Fig. 10, e.g. , between interior and exterior walls of the holder 1 1 14, in alternate embodiments, the heating element 1 124 may be positioned in any suitable location. Additionally, it should be appreciated that, while the temperature control unit 1 122 (Fig. 9) is shown as being integral to the container 1 102 in the illustrated embodiment, in alternate embodiments, the temperature control unit 1 122, or the components thereof, e.g. , the power source 1 126 and/or the controller 1 128, may be located remotely from the container 1 102 without departing from the scope of the present disclosure, e.g. , via wired or wireless communication with the heating element 1 124.

With reference again to Fig. 9, the subsystem 1200 will be discussed. The subsystem 1200 utilizes a multi-solution protocol similar to that discussed above with respect to Figs. l-8d to remove cryoprotectants from the biological sample 102, and to cool the biological sample 102 after warming using the system 1 100 discussed above. The cooling subsystem 1200 includes a repository 1202 that accommodates a series of containers 1204A-1204D (collectively containers 1204) respectively including solutions 1206A-1 06_d, that allow for a gradual/sequential removal of cryoprotectant and a gradual transfer of thermal energy from the biological sample 102, as will be discussed in further detail below. Although shown as including four (4) containers 1204 in the embodiment of the system 1200 illustrated in Fig. 9, it should be appreciated that in alternate embodiments, a different number of containers 1204 could be provided.

The first container 1204A includes a first solution 1206A in a first volume, the second container 1204_B includes a second solution 1206_B in a second volume, the third container 1204c includes a third solution 1206c in a third volume, and the fourth container 1204p includes a fourth solution 1206D in a fourth volume. In the embodiment of Fig. 9, for example, the first container 1204_A includes 2 ml of 1 M sucrose solution in holding medium (i.e. , solution 1206A), the second container 1204B includes 3 ml of .5M sucrose solution in holding medium (i.e. , solution 1206B), the third container 1204c includes 4 ml of .25 M sucrose solution in holding medium (i. e. , solution 1206c), and the fourth container 1204D includes a solution composed entirely of the holding medium (i.e. , solution 1206D). In one specific embodiment, each of the four solutions 1206_A-1206_D may be held at approximately the same temperature, e.g., room temperature (22°C-24°C). In alternate embodiments, however, two or more of the solutions may be held at a different temperature, e.g., the first solution may be held at a first temperature and the second solution may be held at a second different temperature. It should be appreciated, however, that the volumes, concentrations, and temperatures in the containers 1204_a-1204D, as well as the composition of the solutions 1206A-1206D themselves, may be varied in alternate embodiments of the system 1200 to achieve a particular result without departing from the scope of the disclosure. For example, one or more of the containers may contain different types of solutions other than a sucrose solution, a larger or smaller volume than enumerated above can be provided in one or more of the containers, etc., and/or a different number of containers may alternatively be provided.

As discussed above in connection with the subsystem 1 100, in order to maintain and control the temperature of the solutions 1206A-1206D respectively held in the containers 1204_A- 1204_D, the repository 1202 may include, or may be connected to, a temperature control unit 1208. In the embodiment illustrated in Fig. 9, for example, the temperature control unit 1208 includes a heating element 1210 in communication with a power source 1212. To further increase the level of control over the temperature of the solutions 1206_a-1206D, the temperature control unit 1208 may also include a programmable controller 1214, as shown in Fig. 9, to regulate the amount of energy communicated to the solutions 1206_a-1206D. Although shown as being integral to the repository 1202 in the embodiment illustrated in Fig. 9, in alternate embodiments, the temperature control unit 1208, or the components thereof, e.g., the heating element 1210, the power source 1212, and/or the controller 1214, may be may be located remotely from the repository 1202 without departing from the scope of the present disclosure, e.g., via wired or wireless communication.

With reference now to Figs. 9-13, a method of using the system 1000 will be discussed to warm, thaw, cool and reconstitute the biological sample 102 following completion of the cryopreservation procedure discussed above with respect to Figs. l -8d, or following another cryopreservation procedure. Warming, thawing, cooling and reconstituting can be performed at any time after preservation. Although a single biological sample 102 is illustrated in the figures, as discussed above, it should be understood that multiple biological samples may be warmed, thawed, cooled, and reconstituted simultaneously.

Initially, to maintain cryopreservation prior to warming, the biological sample 102 may be positioned within the cryogenic fluid 1 104 housed within the chamber 1 1 10 of the container 1 102, as shown in Fig. 9. As shown, the biological sample 102 is retained on a carrier 1002 external of the heating section of the container 1 102 as it is immersed in the cryogenic fluid 1 104. The carrier 1002, with biological sample 102, can then be subsequently removed from the cryogenic fluid 1 104 and transferred/inserted into the receptacle 1 1 16, and into the warming solution 1 106 contained therein. To assist in placement of the biological sample 102, in one embodiment, a guide element or tubular member (element) 1004, e.g., a medical grade straw, may be used, as shown in Fig. 10. As seen in Fig. 1 1 , the guide element 1004 includes a distal end 1006 having one or more perforations or openings 1008, to allow inflow of fluid, and block passage of biological sample 102, in a manner as discussed above in connection with the pod 200 (Figs. 2a, 2b). By allowing inflow, the warming solution 1 106 begins to fill the guide element (straw) 1004 following insertion of the guide element 1004 into the holder 1 1 14. In the illustrated embodiment, the perforations 1008 are formed on an element (member) supported in the guide element 1004, which can be in the form of a mesh 1010.

Alternatively, the biological sample 102 may be positioned/retained in the cryogenic fluid 1 104 using the aforedescribed tube and pod arrangement of Figs. l -8d. That is, as described in the embodiments of Figures l -8d, the carrier 1002 can be in the form of the coupled tube/pod arrangement, the pod containing orifices as described above for inflow of liquid. The tube/pod arrangement would then be transferred from the cryogenic fluid 1 104 into the warming solution 1 106 for warming in the same manner as described for carrier 1002.

In one method of use, the guide element 1004 may be prepositioned in the warming solution 1 106 prior to introduction of the biological sample 102, as shown in Fig. 9. The carrier 1002 with the biological sample 102 is introduced into the pre- warmed guide element 1004, which is isolated from the cryogenic fluid 1 104 by the insulating wall 1 108. Alternatively, the guide element 1004 and the biological sample 102 may be placed together in the cryogenic fluid 1 104, and then together relocated from the cryogenic fluid 1 104 into the receptacle 1 1 16 such that the guide element 1004 and the biological sample 102 are introduced into the warming solution 1 106 simultaneously.

In other words, there are three options for transferring the biological sample 102 from the cryogenic fluid 1 104 into the warming solution 1 106, as depicted in FIG. 15. In the first option, the carrier 1002, the biological sample 102, and the guide element (straw) 1004 can be collectively moved from the cryogenic fluid 1 104 into the warming solution 1 106. In the second option, the guide element (straw) 1004 may be prepositioned in the warming solution 1 106, and the carrier 1002 and the biological sample can then be inserted into the pre-warmed guide element (straw) 1004. In the third option, the biological sample 102 may be retained in the cryogenic fluid 1 104 using the tube 100 and pod 200 arrangement of Figs. l-8d, and the tube 100 and pod 200, with the biological sample 102 positioned therein, can be transferred from the cryogenic fluid 1 104 into the warming solution 1 106. As can be appreciated, the steps of Fig. 15 correspond to options applicable to box 1 (the first step) of Fig. 13.

During transfer of the biological sample 102 into the warming solution 1 106, the biological sample 102 passes through vapor "V" formed by the cryogenic fluid 1 104 within the container 1 102, e.g., liquid nitrogen vapor, which closely approximates the glass temperature (T_g) of the warming solution 1 106 to reduce fraction of the vitrified drop. The close proximity of the solutions 1 104, 1 106 achievable by the configuration of the container 1 102 allows for a rapid transfer of the biological sample 102 from the cryogenic fluid 1 104 into the warming solution 1 106, e.g., in an interval of about 0.1 seconds to about 5 seconds, which results in minimal air exposure and an accelerated warming rate on the order of 20,000°C/min or more. This increased warming rate and reduced exposure interval reduce devitrification or recrystallization that might otherwise occur during warming of the biological sample 102, and thereby minimize potential cellular damage and/or the potential for toxicity.

After insertion of the biological sample 102 into the warming solution 1 106, the biological sample 102 increases in temperature, e.g., to 37°C, as discussed above, and detaches from the carrier 1002, which can then be discarded. The biological sample 102 remains positioned within the warming solution 1 106 for a period of time, e.g., a few seconds to one (1) minute, to allow for an initial purging of cryoprotectant from the biological sample 102 and replacement by water from the warming solution 1 106 during osmotic balancing.

Once the biological sample 102 has been warmed to the desired temperature, the biological sample 102 can be transferred into the cooling subsystem 1200, e.g., via the guide element 1004 (or the tube 100 and pod 200 seen in Figs. 1 , 2a), to bring the temperature of the biological sample 102 down to a particular level, e.g., room temperature (22°C-24°C), as discussed above in accordance with an embodiment that subsequently utilizes the system 1200.

During the cooling process, the biological sample 102 is systematically moved from the receptacle 1 1 16 through the containers 1204A- 1204D and the solutions 1206A- 1206D respectively contained therein. Specifically, the biological sample 102 is moved from the receptacle 1 1 16 into the first container 1204_A, and is held in the first solution 1206A contained therein for a period of time, e.g., 2.5 minutes. The biological sample 102 is then moved from the first container 1204_Λ into the second container 1204B, and is held in the second solution 1206B contained therein for a period of time, e.g., 2.5 minutes, then from the second container 1204B into the third container 1204c. The biological sample 102 is held in the third solution 1206c in the third container 1204B for a period of time, e.g., 2.5 minutes, and is then transferred from the third container 1204c into the fourth container 1204p for a final wash in the fourth solution 1206D, e.g., the holding medium. Movement of the biological sample 102 through the containers 1204A-1204D may be accomplished either manually via step by step placement and withdrawal from the containers 1204_a-1204D, or alternatively, may be performed robotically with a robot arm moving and immersing the biological sample 102 contained in the guide element 1004 into the containers 1204A-1204D respectively containing the various solutions 1206A-1206D step by step. The times for immersion in the solutions 1206_a-1206D are provided by way of example, as the biological sample 102 can be held in the solutions 1206A-1206D for other time intervals. Also, as noted above, a different number of containers 1204A-1 04O and/or solutions 1206A- 1206D may be utilized. During movement of the biological sample 102 through the containers 1204A-1204D, the biological sample 102 will float and sink within the guide element 1004 (or the tube 100 seen in Fig. 1) as the different solutions 1206A-1206D mix by virtue of their disparate densities, as discussed above with respect to Figs. 7a-8d. However, the process can be considered sort of the reverse of the process of Figs. 7a-8d since the solutions can be of progressively decreasing densities rather than progressively increasing densities. In one exemplary embodiment, the concentration of the sucrose solution progressively decreases in subsequent solutions. For example, as the biological sample 102 moves from the (more dense) second solution 1206B into the (less dense) third solution 1206c, the (less dense) third solution 1206c will float up through the (more dense) second solution 1206B together with the biological sample 102. As cryoprotectant is progressively reduced and purged from the biological sample 102, and replaced with less dense solution during movement through the containers 1204A-1204D, the biological sample 102 will continually float upwards (proximally) through the various solutions 1206A- 1206D introduced into the guide element 1004 away from the distal end 1006 thereof.

After the purging of cryoprotectant and cooling of the biological sample 102, the biological sample 102 can be transferred from the guide element 1004 (or the tube 100 seen in Fig. 1 ), e.g., into a petri dish, for further evaluation and/or clinical treatment. To facilitate transfer of the biological sample, the distal end 1006 of the guide element 1004 including the mesh 1010 may be removed, e.g., by cutting.

As can be appreciated, the repository 1200 provides a system utilized subsequent to the warming achieved by the container 1 102. This subsequent system cools and further reduces the cryoprotectant concentration within the biological sample 102 to facilitate further use, evaluation, and/or treatment.

The foregoing embodiment of Fig. 9 describes insertion of the carrier 1002 and the biological sample 102 into the pre- warmed guide element 1004, which is isolated from the cryogenic fluid 1 104 in the container 1 102. In an alternate embodiment, the biological sample 102 may be inserted into the guide element 1004 under cryogenic fluid 1 104, and then the guide element 1004 may be plunged into the warming solution 1 106. After warming, the biological sample 102 may be placed into the cooling and purging system 1200 (Fig. 9), e.g., via the guide element 1004.

As can be appreciated through reference to the foregoing discussion, the system 1200 achieves simultaneous purging of cryoprotectant from the biological sample 102, and cooling of the biological sample 102.

Cryopreservation and Subsequent Warming, Thawing, and Reconstitution

As noted above, the present invention also provides a system which combines the systems of Figs. 1-8 and the system of Figs. 9-13. This is depicted in the flow chart of Fig. 14 wherein the first steps involve vitrification of the biological sample 102 for cryopreservation, and the subsequent steps, which can be performed at any time after cryopreservation, involve the steps of Figs. 9-13. In short, the assembly of the tube 100 (Fig. 1 ) and pod 200 (Fig. 2a) would be thawed and reconstituted in the container 1 102 of the system 1000 seen in Figure 9.

More specifically, in the first steps, one or more biological samples 102 may be loaded into the tube 100, e.g., into the capillary duct 108 (Fig. 1 ). The distal end 104 of the tube 100 may then be coupled to the pod 200 (Fig 2a), as described above. The assembled tube 100 and pod 200 may then be immersed sequentially into a series of solutions, as discussed above in connection with FIGS. 5 and 8. The assembled tube 100 and pod 200 may then be inserted into a cryogenic fluid, e.g., liquid nitrogen, and stored for a desired amount of time.

When it is desired to warm the biological sample(s) 102, which can occur at any time after cryopreservation, whether shortly thereafter or in the distant future, any of the methods discussed above (FIG. 15) may be used to transfer the biological sample(s) 102 from the cryogenic fluid 1 104 (FIG. 9), into a warming solution, e.g., the warming solution 1 106, such as, for example, by transferring the assembled tube 100 and pod 200 together with the biological sample(s) 102 contained therein from the cryogenic fluid 1 104 into warming solution 1 106. Subsequently, the biological sample(s) may be transferred, e.g., from the container 1 102, into the cooling subsystem 1200, using the assembled tube 100 and pod 200, for example, and moved sequentially through the solutions 1206_a-1206D respectively retained in the containers 1204_A- 1204D to warm, thaw, and reconstitute the biological sample(s) 102.

As can be appreciated there are several options for transferring into the warming solution and these are depicted in the flow chart of Fig. 15. In other words, the steps of Fig. 15 correspond to options applicable to box 5 of Fig. 13.

As can be appreciated, the straws used in the cryopreservation and/or warming/thawing procedures described herein can exhibit capillarity with the features and advantages discussed above.

Although various embodiments of the invention have been described above, these are only given for the purpose of explanation of the present invention and the range of the present invention should not be considered as being limited only to these embodiments.

While the above description contains many specifics, those specifics should not be construed as limitations on the scope of the disclosure, but merely as exemplifications of the disclosed embodiments thereof. Those skilled in the art will envision many other possible variations that are within the scope and spirit of the disclosure as defined by the claims appended hereto.

Claims

CLAIMS:

1. A system for use in warming a cryopreserved biological sample, the system comprising: a heating system configured and dimensioned to raise a temperature of the biological sample, the heating system including a container retaining a cryogenic fluid and a warming solution in close proximity such that the biological sample is movable from the cryogenic fluid into the warming solution in an interval of time resulting in reduced air exposure and an increased warming rate to reduce cellular damage during warming.

2. The system of claim 1 , wherein the container includes an insulating wall separating the cryogenic fluid and the warming solution, the insulating wall defining a chamber configured and dimensioned to retain the cryogenic fluid, and a receiving space configured and dimensioned to receive a receptacle configured and dimensioned to retain the warming solution.

3. The system of claim 2, wherein the insulating wall separates the receptacle from the cryogenic fluid such that the interval of time is within the range of about .1 seconds to about 5 seconds.

4. The system of claim 2, further including a holder positioned within the receiving space, the holder being configured and dimensioned to receive the receptacle.

5. The system of claim 4, wherein the insulating wall defines an inwardly extending shoulder configured and dimensioned to provide a seat for the holder.

6. The system of claim 2, wherein the insulating wall defines a thickness within the range of about 5 cm to about 10 cm, whereby the interval of time is within the range of about .1 seconds to about 5 seconds.

7. The system of claim 1 , wherein the container further includes a temperature control unit to heat the warming solution to a desired temperature.

8. The system of claim 7, wherein the temperature control unit includes a programmable controller to facilitate regulation of the temperature of the warming solution.

9. The system of claim 1 , further including a cooling system to cool the biological sample from the first temperature to a second temperature, the cooling system including a repository including a plurality of containers including a first container retaining a first solution in a first volume, and a second container retaining a second solution in a second volume greater than the first volume.

10. The system of claim 9, wherein the first solution and the second solution are the same except the first solution is more dense than the second solution.

1 1. The system of claim 10, wherein the first solution includes about 2 ml of 1M sucrose solution in holding medium and the second solution includes about 3 ml of .5M sucrose solution in holding medium.

12. The system of claim 1 1, wherein the first and second solutions are each held at temperatures within the range of about 22°C to about 24°C.

13. The system of claim 9, wherein the repository includes a temperature control unit to regulate temperature of the first solution and the second solution.

14. A system for warming a cryopreserved biological sample, the system comprising: a container having an insulating wall defining first and second areas, the first area being configured and dimensioned to receive a cryogenic fluid to maintain cryopreservation of the sample, and the second area being configured and dimensioned to receive a warming solution to warm the biological sample.

15. The system of claim 14, further comprising a cooling system including a plurality of containers for receiving solutions, the containers progressively removing cryoprotectant from the biological sample.

16. A system for treating a biological sample after being cryopreserved and warmed, the system comprising a cooling system to cool the biological sample from a first temperature to a second cooler temperature, the cooling system including a repository including a plurality of containers, the plurality of containers including a first container retaining a first solution, and a second container retaining a second solution, wherein the biological sample is movable from the first solution to the second solution to remove cryoprotectant.

17. The system of claim 16, wherein the biological sample is contained in a tube having a perforated member at a distal end, the tube being insertable into the first container and then into the second container.

18. The system of claim 16, wherein the second temperature is about room temperature.

19. The system of claim 14, further comprising a temperature control unit including a programmable controller to facilitate regulation of the temperature of the first and second solutions.

20. A method of warming a cryopreserved biological sample, the method comprising:

removing the biological sample from a cryogenic fluid retained within a chamber defined by an insulating wall of a container; and

inserting the biological sample into a warming solution retained within a receiving space defined by the insulating wall of the container.

21. The method of claim 20, wherein inserting the biological sample into the warming solution includes passing the biological sample through vapor formed by the cryogenic fluid.

22. The method of claim 20, wherein removing the biological sample from the cryogenic fluid and inserting the biological sample into the warming solution is completed in an interval of time within the range of about .1 seconds to about 5 seconds.

23. The method of claim 20, further including the step of removing the biological sample from the warming solution, and inserting the biological sample into a first solution.

24. The method of claim 23, further including removing the biological sample from the first solution and inserting the biological sample into a second solution, wherein the first solution is more dense than the second solution.

25. The method of claim 24, wherein inserting the biological sample into the first solution includes inserting the biological sample into 2 ml of 1 M sucrose solution in holding medium, and inserting the biological sample into the second solution includes inserting the biological sample into 3 ml of .5M sucrose solution in holding medium.

26. A cryopreservation and warming system for use in preserving a biological sample, the system comprising:

a device for retaining a biological sample for performing a cryoprocedure on the biological sample, the device including a tubular member having a lumen extending therein and a perforated member; and

a heating system configured and dimensioned to receive the device and heat the biological sample to a first temperature following the cryoprocedure.

27. The system of claim 26, further comprising a cooling system configured and dimensioned to cool the biological sample from the first temperature to a second temperature following removal from the heating system.

28. The system of claim 27, wherein the cooling system includes a repository accommodating a plurality of containers retaining solution to remove cryoprotectant step by step from the biological sample.

29. The system of claim 28, wherein the device further includes a retainer couplable to a distal end of the tubular member, the retainer having the perforated member having at least one orifice, the at least one orifice having a dimension smaller than a dimension of the at least one biological sample to prevent exit of the biological sample from the tubular member, wherein the perforated member is configured to allow inflow of liquids to communicate with the lumen containing the biological sample.

30. The system of claim 29, wherein the perforated member comprises a mesh.

31. The system of claim 26, wherein the heating system includes a container with an insulating wall, the insulating wall defining a chamber configured and dimensioned to retain a cryogenic fluid.

32. The system of claim 31 , wherein the insulating wall further defines a receiving space configured and dimensioned to removably receive a receptacle configured and dimensioned to retain a warming solution such that the cryogenic fluid and the warming solution are positioned in close proximity, whereby the biological sample is movable from the cryogenic fluid into the warming solution in an interval of time that results in reduced air exposure and an increased warming rate to reduce cellular damage.

33. The system of claim 32, wherein the insulating wall separates the receptacle from the cryogenic fluid and defines a thickness within the range of about .5 cm to about 10 cm, whereby the interval of time is within the range of .1 seconds to 5 seconds.

34. The system of claim 32, wherein the container further includes a temperature control unit to heat the warming solution to a desired temperature.

35. The system of claim 27, further comprising a plurality of containers, wherein the containers contain solutions of different densities.

36. The system of claim 35, wherein the containers contain solutions of different densities which receive the biological sample step by step to add cryoprotectant to the biological sample.

37. The system of claim 35, wherein the containers contain solutions of different densities which receive the biological sample step by step to remove cryoprotectant from the biological sample.

38. The system of claim 35, wherein the cooling system includes a temperature control unit.

39. A method for a cryopreserving and warming a biological sample, the method comprising: loading the biological sample into a tubular member;

positioning the tubular member and the biological sample in a cryogenic fluid;

removing the tubular member and the biological sample from the cryogenic fluid; and positioning the tubular member and the biological sample in a warming solution held within the container.

40. The method of claim 39, wherein positioning the tubular member and the biological sample includes retaining the biological sample within the tubular member with a perforated member having at least one orifice defining a dimension smaller than a dimension of the biological sample to prevent exit of the biological sample from the tubular member.

41. The method of claim 40, wherein removing the tubular member and the biological sample from the cryogenic fluid includes removing the tubular member and the biological sample from a chamber defined by an insulating wall of the container.

42. The method of claim 41 , wherein positioning the tubular member and the biological sample in the warming solution includes inserting the biological sample into a receiving space defined by the insulating wall of the container.

43. The method of claim 42, wherein positioning the tubular member and the biological sample in the warming solution includes passing the biological sample through vapor formed by the cryogenic fluid.

44. The method of claim 39, wherein removing the tubular member and the biological sample from the cryogenic fluid and positioning the biological sample in the warming solution is completed in an interval of time within the range of about .1 seconds to about 5 seconds.

45. The method of claim 43, further including removing the tubular member and the biological sample from the warming solution, and inserting the tubular member and the biological sample into a first cooling solution.

46. The method of claim 45, further including removing the tubular member and the biological sample from the first cooling solution and inserting the tubular member and the biological sample into a second cooling solution, wherein the first cooling solution and the second cooling solution include the same components, the first solution being more dense than the second solution.